BlueCrest Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

BlueCrest Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-30,643	Closed	-$119K	–	1666
2017 Q4	$119K	Buy	+30,643	New	+$131K	﹤0.01%	753
2016 Q3	–	Sell	-1,573	Closed	-$4K	–	1033
2016 Q2	$4K	Buy	+1,573	New	+$4.38K	﹤0.01%	836

Other funds holding CDMO

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SIC

Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlueCrest Capital Management's CDMO Position: Q1 2018 in Review

BlueCrest Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2018, closing a stake of 30,643 shares — an estimated $119K sold.

BlueCrest Capital Management first reported a position in CDMO in Q2 2016 and held it in 2 quarters. The position peaked at $119K in Q4 2017. 70 funds tracked by Wall St. Rank hold CDMO as of Q1 2018.

BlueCrest Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
BlueCrest Capital Management sold 30,643 Avid Bioservices, Inc. Common Stock shares in Q1 2018, an estimated $119K.
BlueCrest Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
BlueCrest Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $119K in Q4 2017.
70 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2018.

Based on BlueCrest Capital Management's 13F filing for Q1 2018, filed 15 May 2018.